Andrew Kenneth William Powell - Nov 8, 2022 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 04:08 PM
Previous filing
Jun 13, 2022
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Gift $0 -4K -28.87% $0.00 9.86K Nov 8, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.